https://www.nice.org.uk/guidance/ng12/chapter/1-Recommendations-organised-by-site-of-cancer#urological-cancers<\/a><\/p> <\/p>
Over the last two financial years, over £200 million funding has been provided through our Cancer Alliances to transform earlier diagnosis and personalised care.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2019-02-06", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "213989"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-02-06T15:09:56.6Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-01-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Kidney Cancer"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps the Government plans to take in the next five years to reduce the number of patients with kidney cancer who are misdiagnosed; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1521", "label" : {"_value" : "Biography information for Mrs Sharon Hodgson"}
}
, "tablingMemberConstituency" : {"_value" : "Washington and Sunderland West"}
, "tablingMemberPrinted" : [{"_value" : "Mrs Sharon Hodgson"}
], "uin" : "213990"}
, {"_about" : "http://data.parliament.uk/resources/1050634", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1050634/answer", "answerText" : {"_value" : "
The UK National Screening Committee (UK NSC) advises ministers and the National Health Service in all four nations about all aspects of screening policy and supports implementation. Using research evidence, pilot programmes and economic evaluation, it assesses the evidence for programmes against a set of internationally recognised criteria.<\/p>
<\/p>
The UK NSC has not reviewed the evidence for a national screening programme for kidney cancer. Therefore an assessment of the potential merits of allocating funding for research has not been made.<\/p>
<\/p>
Nevertheless, Public Health England has funded a Be Clear on Cancer \u2018Blood in pee\u2019 campaign which ran across England from July to September 2018, which aimed to raise awareness and improve early diagnosis of bladder and kidney cancer.<\/p>
<\/p>
The NHS Long Term Plan, published on 7 January, sets out a comprehensive package of measures that will transform cancer diagnosis and treatment across the country over the next 10 years; a decade in which patients can expect to see huge improvements in the prevention, diagnosis and treatment of cancer. The aim is to see 55,000 more people surviving cancer for five years in England each year from 2028.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2019-02-06", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-02-06T15:23:44.017Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-01-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Kidney Cancer"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, whether the Government has made an assessment of the potential merits of allocating funding to research into the development of a national screening programme for kidney cancer; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1521", "label" : {"_value" : "Biography information for Mrs Sharon Hodgson"}
}
, "tablingMemberConstituency" : {"_value" : "Washington and Sunderland West"}
, "tablingMemberPrinted" : [{"_value" : "Mrs Sharon Hodgson"}
], "uin" : "213991"}
, {"_about" : "http://data.parliament.uk/resources/1050635", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1050635/answer", "answerText" : {"_value" : "
The NHS Long Term Plan included an ambition that 55,000 more people who are diagnosed with cancer in 2028 will survive for five years. Early diagnosis is a major determinant of cancer survival and NHS England have deliberately set the early diagnosis ambition \u2013 to diagnose 75% of cancers at stage 1 and 2 by 2028 - at a level which, under most scenarios, would be more than sufficient to meet the survival ambition. During the development of the plan, clinicians and stakeholders agreed that we should set a stretching ambition to ensure we improve the rate of diagnosis across all cancers, so many more people will survive.<\/p>
<\/p>
The NHS Long Term Plan sets out a number of key steps to achieve this ambition, including through raising greater awareness of symptoms of cancer, accelerating access to diagnosis and treatment and maximising the number of cancers that we identify through screening. Meeting this ambition will also require the National Health Service to harness new technological advances to target at risk patients more effectively; directing our research and innovation effort to the areas where the data tells us we can have the biggest impact; and mobilising the NHS so that we can adopt proven new approaches more quickly.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2019-02-06", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "213993"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-02-06T15:17:34.977Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-01-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Cancer"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to the NHS Long Term Plan, what recent steps he has taken to implement the target of diagnosing 75 per cent of cancers at stage one or stage two by 2028; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1521", "label" : {"_value" : "Biography information for Mrs Sharon Hodgson"}
}
, "tablingMemberConstituency" : {"_value" : "Washington and Sunderland West"}
, "tablingMemberPrinted" : [{"_value" : "Mrs Sharon Hodgson"}
], "uin" : "213992"}
, {"_about" : "http://data.parliament.uk/resources/1050636", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1050636/answer", "answerText" : {"_value" : "
The NHS Long Term Plan included an ambition that 55,000 more people who are diagnosed with cancer in 2028 will survive for five years. Early diagnosis is a major determinant of cancer survival and NHS England have deliberately set the early diagnosis ambition \u2013 to diagnose 75% of cancers at stage 1 and 2 by 2028 - at a level which, under most scenarios, would be more than sufficient to meet the survival ambition. During the development of the plan, clinicians and stakeholders agreed that we should set a stretching ambition to ensure we improve the rate of diagnosis across all cancers, so many more people will survive.<\/p>
<\/p>
The NHS Long Term Plan sets out a number of key steps to achieve this ambition, including through raising greater awareness of symptoms of cancer, accelerating access to diagnosis and treatment and maximising the number of cancers that we identify through screening. Meeting this ambition will also require the National Health Service to harness new technological advances to target at risk patients more effectively; directing our research and innovation effort to the areas where the data tells us we can have the biggest impact; and mobilising the NHS so that we can adopt proven new approaches more quickly.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2019-02-06", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "213992"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-02-06T15:17:35.023Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-01-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Cancer"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what the evidential basis was for his Department's target of diagnosing 75 per cent of cancers at stage one or stage two by 2028 and if he made an assessment of the feasibility of setting that target at 2025.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1521", "label" : {"_value" : "Biography information for Mrs Sharon Hodgson"}
}
, "tablingMemberConstituency" : {"_value" : "Washington and Sunderland West"}
, "tablingMemberPrinted" : [{"_value" : "Mrs Sharon Hodgson"}
], "uin" : "213993"}
, {"_about" : "http://data.parliament.uk/resources/1050637", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1050637/answer", "answerText" : {"_value" : "
The consultation for the 2019/20 national tariff is currently live and information can be found at the following link:<\/p>
<\/p>
https://improvement.nhs.uk/resources/national-tariff-1920-consultation/<\/a><\/p> <\/p>
It is proposed that radiofrequency, cryotherapy and microwave ablation probes and catheters should remain on the list.<\/p>
<\/p>
The current proposals are for a one year tariff and no decisions have been made on the composition of the high cost excluded device list for future years.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"}
}
, "answeringMemberConstituency" : {"_value" : "Wimbledon"}
, "answeringMemberPrinted" : {"_value" : "Stephen Hammond"}
, "dateOfAnswer" : {"_value" : "2019-02-06", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-02-06T17:28:28.843Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-01-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Medical Equipment"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, whether cryoablation needles will remain available through the High Cost Tariff Excluded Device List with no changes to current funding arrangements in each of the next five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1521", "label" : {"_value" : "Biography information for Mrs Sharon Hodgson"}
}
, "tablingMemberConstituency" : {"_value" : "Washington and Sunderland West"}
, "tablingMemberPrinted" : [{"_value" : "Mrs Sharon Hodgson"}
], "uin" : "213994"}
, {"_about" : "http://data.parliament.uk/resources/1050044", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1050044/answer", "answerText" : {"_value" : "
In the event of the United Kingdom leaving the European Union without a deal, the Tobacco Products and Nicotine Inhaling Products (Amendment etc.) (EU Exit) Regulations 2019 allow for tobacco products produced before exit day, with EU picture warnings, to be sold for 12 months after exit day. Any products manufactured after exit day will need to include the new picture health warnings which are introduced by the above legislation.<\/p>
<\/p>
Tobacco products and e-cigarettes which have been notified via the EU notification system prior to exit day will not need to be notified again after exit day, unless there are substantive change to products.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2019-02-05", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-02-05T15:00:31.393Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-01-28", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Tobacco: Sales"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to the Tobacco Products and Nicotine Inhaling Products (Amendment etc.) (EU Exit) Regulations 2018, whether products produced before the UK leaves the EU will still be legal to sell after the UK leaves the EU.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1521", "label" : {"_value" : "Biography information for Mrs Sharon Hodgson"}
}
, "tablingMemberConstituency" : {"_value" : "Washington and Sunderland West"}
, "tablingMemberPrinted" : [{"_value" : "Mrs Sharon Hodgson"}
], "uin" : "213284"}
, {"_about" : "http://data.parliament.uk/resources/1045483", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1045483/answer", "answerText" : {"_value" : "
The Department is conducting a short, focussed internal review of the provisions for parents of premature and sick babies and those that experience multiple births. The purpose of this work is to obtain a high-level understanding of the barriers to participating in the labour market that these parents can face.<\/p>
BEIS officials are working with organisations who represent the interests of these parents (The Smallest Things, Bliss, and TAMBA) to better understand the issues that parents can face and have also held focus groups with a small number of parents themselves.<\/p>
We are also considering options for addressing other information gaps \u2013 including those that are attributable to regional variations in provision and experiences of parents.<\/p>
<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4487", "label" : {"_value" : "Biography information for Kelly Tolhurst"}
}
, "answeringMemberConstituency" : {"_value" : "Rochester and Strood"}
, "answeringMemberPrinted" : {"_value" : "Kelly Tolhurst"}
, "dateOfAnswer" : {"_value" : "2019-01-28", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "210496"}
, {"_value" : "210497"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-01-28T15:38:08.337Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "201"}
, "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"}
, "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"}
, "date" : {"_value" : "2019-01-21", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Employment: Parents"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, whether his Department has consulted (a) parents, (b) employers and (c) other organisations as part of its internal review of workplace provision for parents of premature babies.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1521", "label" : {"_value" : "Biography information for Mrs Sharon Hodgson"}
}
, "tablingMemberConstituency" : {"_value" : "Washington and Sunderland West"}
, "tablingMemberPrinted" : [{"_value" : "Mrs Sharon Hodgson"}
], "uin" : "210495"}
], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&tablingMemberConstituency=Washington+and+Sunderland+West&max-date=2019-02-01", "page" : 0, "startIndex" : 1, "totalResults" : 918, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}